Cargando…
Shortages and price variability of essential cytotoxic medicines for treating children with cancers
INTRODUCTION: Low-income and middle-income countries (LMICs) face the largest burden of mortality from childhood cancers with limited access to curative therapies. Few comparative analyses across all income groups and world regions have examined the availability and acquisition costs of essential me...
Autores principales: | Martei, Yehoda M, Iwamoto, Kotoji, Barr, Ronald D, Wiernkowski, John T, Robertson, Jane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656942/ https://www.ncbi.nlm.nih.gov/pubmed/33173011 http://dx.doi.org/10.1136/bmjgh-2020-003282 |
Ejemplares similares
-
Patent pooling to increase access to essential medicines
por: Burrone, Esteban, et al.
Publicado: (2019) -
Availability of WHO Essential Medicines for Cancer Treatment in Botswana
por: Martei, Yehoda M., et al.
Publicado: (2018) -
Medicines for cancers in children: The WHO model for selection of essential medicines
por: Robertson, Jane, et al.
Publicado: (2015) -
Access to and Affordability of World Health Organization Essential Medicines for Cancer in Sub-Saharan Africa: Examples from Kenya, Rwanda, and Uganda
por: Kizub, Darya A, et al.
Publicado: (2022) -
Identifying patients at high risk of breast cancer recurrence: strategies to improve patient outcomes
por: Martei, Yehoda M, et al.
Publicado: (2015)